Increased hepassocin plasma levels in MASLD subjects (Wu et al., 2013)Higher plasma hepassocin levels in obese individuals (Huang et al., 2020)Increased plasma hepassocin in patients with T2DM (Abdelmoemen et al., 2019). The gene discussed is FGL1; the disease is type 2 diabetes mellitus.